Introduction
============

Voltage-gated Ca~v~1.3 Ca^2+^ channels represent a member of the dihydropyridine-sensitive class of L-type Ca^2+^ channels (LTCCs). Together with Ca~v~1.2 LTCCs they are expressed in mammalian electrically excitable tissues. Ca~v~1.3 knockout mice[@R1]^-^[@R3] and a recently discovered human disease (Sinoatrial Node Dysfunction and Deafness, SANDD)[@R4] revealed a key role of these channels for hearing, cardiac pacemaker function and neuronal excitability. Ca~v~1.3 channels possess unique gating properties that privilege them to carry Ca^2+^ inward currents at threshold potentials in sinoatrial node cells,[@R2] chromaffin cells[@R5] neurons as well as within the operating range of cochlear inner hair cells.[@R6]^,^[@R7] These gating properties are tightly controlled by a C-terminal modulatory domain (CTM) with strong effects on Ca~v~1.3 activation and inactivation gating behavior as well as open probability (Po).[@R8]^-^[@R10] The CTM is formed by an intermolecular protein-protein interaction of a distal (DCRD) with a proximal C-terminal modulatory domain (PCRD), thereby decreasing the calmodulin affinity for the channel.[@R11]^,^[@R12] Alternative splicing within the Ca~v~1.3 C-terminus is tissue-specific and involves structural motifs required for high affinity interaction with calmodulin and the proper function of the CTM. Since calmodulin serves as the Ca^2+^ sensor for autoinhibitory Ca^2+^-dependent inactivation (CDI) of voltage-gated Ca^2+^ channels, splicing causes pronounced gating differences between long and short Cav1.3.[@R8]^,^[@R9]^,^[@R11]^,^[@R13]^,^[@R14] Short CTM-deficient splice variants have higher Po, activate at more negative voltages and show accelerated CDI than full length variants with a functional CTM (Ca~v~1.3~L~).[@R8]^,^[@R9] This modulatory domain has been extensively characterized with cDNA constructs cloned from human pancreas,[@R8]^,^[@R9] and its effects were also reproduced with short and long mouse constructs (unpublished observations). In contrast, the modulation was not reported for Ca~v~1.3 channels cloned from rat superior cervical ganglia neurons (scg) (termed rCa~v~1.3~scg~).[@R15] Despite the presence of a full length C-terminal tail, rCa~v~1.3~scg~ showed gating properties similar to those observed in short splice variants,[@R11]^,^[@R15]^-^[@R20] suggesting a dysfunctional CTM. It is at present unclear if this could represent a significant species difference in Ca~v~1.3 channel modulation and to which extent transcripts corresponding to rCa~v~1.3~scg~ are expressed in rat scg (and perhaps other tissues). Despite considerable use of rCa~v~1.3~scg~ constructs in Ca~v~1.3 research[@R11]^,^[@R13]^-^[@R18] it has never been tested if corresponding transcripts indeed exist. Moreover, the molecular determinants responsible for the observed functional differences between rCa~v~1.3~scg~ and other rat and mammalian Ca~v~1.3~L~ α~1~-subunits have never been systematically analyzed although they could provide novel information about structural features controlling channel gating. Here we provide bioinformatic and biochemical evidence that rCa~v~1.3~scg~ transcripts are indeed not expressed at detectable levels in rat scg and should therefore not be considered to be contributing to Ca~v~1.3 functional diversity. We took advantage of the minor aa differences between rCa~v~1.3~scg~ and the long rCa~v~1.3 α~1~-subunit (rCa~v~1.3~L~) predicted from the rat cacna1d gene. This allowed us to identify these residues as those responsible for the abnormal gating behavior of rCa~v~1.3~scg~ and as key elements in Ca~v~1.3 Ca^2+^ channel gating.

Results
=======

Major gating differences between rCa~v~1.3~L~ and rCa~v~1.3~scg~
----------------------------------------------------------------

We have recently discovered that an intramolecular protein interaction within the C-terminus of long Ca~v~1.3 α~1~-subunit splice variants forms CTM that stabilizes a gating mode with activation at a more positive voltage range, slower CDI and lower Po. When analyzed under identical experimental conditions after expression in tsA-201 cells, we found that this regulation is present in the long variant of human Ca~v~1.3 (Ca~v~1.3~L~)[@R9] and the common rat rCa~v~1.3 α~1~-subunit originally isolated from rat pancreas (termed rCa~v~1.3~L~ in analogy to the human Ca~v~1.3~L~ containing a full length C-terminal tail[@R8]) but not in the corresponding long rat rCa~v~1.3 variant isolated from scg (rCa~v~1.3~scg~). The activation threshold and V~0.5~ of rCa~v~1.3~scg~ was about 16 mV more negative ([Fig. 1A](#F1){ref-type="fig"}, [Table 1](#T1){ref-type="table"}) and the inactivation time course of Ca^2+^ currents (I~Ca~) was significantly faster than for rCa~v~1.3~L~ ([Fig. 1B](#F1){ref-type="fig"}, [Table 2](#T2){ref-type="table"}) and human Ca~v~1.3~L~ (not shown, cf.[@R8]^,^[@R9]). Faster inactivation was due to enhanced CDI as evident from the even slower inactivation when equimolar Ba^2+^ served as the charge carrier (I~Ba~, [Figure 1B](#F1){ref-type="fig"}). This finding indicates potential species differences or the existence of a scg-specific Ca~v~1.3 splice variant. We therefore investigated the expression of the rCa~v~1.3~scg~ variant in rat scg.

![**Figure 1.** Gating differences between rCa~v~1.3~scg~ and rCa~v~1.3~L~. (A) Normalized voltage activation range of rCa~v~1.3~scg~ (○) and rCa~v~1.3~L~ (●). Activation parameters are given in [Table 1](#T1){ref-type="table"}. Data points are means ± SE. Error bars are often smaller than symbol size. (B) Inactivation of I~Ca~ (scg, L) and I~Ba~ (L Ba^2+^, scg Ba^2+^) of rCa~v~1.3~scg~ and rCa~v~1.3~L~ during the first 500 ms of a 2.5 sec test pulse to V~max~. Inactivation parameters obtained by fitting the data to a double exponential function are given in [Table 2](#T2){ref-type="table"}. Data are shown as means (black line) with SE (gray). (C) Representative experiments, described in B and corresponding fits are illustrated.](chan-6-197-g1){#F1}

###### **Table 1.** Biophysical properties of rCa~v~1.3 α~1~-subunit mutations

  ------------------------------- --------------------- -------------------- ---------------- -------------- ----
  Ca~v~1.3 construct              V0.5                  act tresh            kact             Vrev           n
  rCa~v~1.3~scg~                  -21.34 ± 0.98         -50.30 ± 0.89        8.51 ± 0.30      63.38 ± 1.07   23
  rCa~v~1.3~L~                    -5.19 ± 0.73^aaa^     -39.43 ± 0.51^aaa^   9.10 ± 0.12      65.37 ± 0.62   55
  rCa~v~1.3~scg~ construct                                                                                    
  7M2K                            -22.51 ± 1.45         -48.87 ± 1.53        7.43 ± 0.28^a^   65.78 ± 1.38   11
  S244G                           -18.29 ± 1.14         -44.27 ± 1.10^aaa^   7.37 ± 0.30^a^   61.25 ± 1.75   12
  V1104A                          -22.98 ± 1.59         -50.14 ± 0.67        7.63 ± 0.29      65.40 ± 1.39   9
  A2075V                          -15.49 ± 0.76^aaa^    -48.22 ± 0.76        9.09 ± 0.11      64.60 ± 0.67   31
  S244G/A2075V                    -11.20 ± 0.78 ^bbb^   -43.47 ± 0.64^bbb^   8.86 ± 0.17      65.22 ± 1.15   30
  V1104A/A2075V                   -14.00 ± 1.29         -47.51 ± 1.00        9.05 ± 0.26      65.25 ± 1.53   7
  7M2K/S244G/A2075V               -11.66 ± 0.91         -44.15 ± 1.39        8.88 ± 0.24      62.87 ± 0.88   11
  S244G/V1104A/A2075V             -10.23 ± 0.88         -42.59 ± 0.89        8.75 ± 0.27      63.93 ± 1.14   12
  S244G/V1104A/ex31A/A2075V       -8.87 ± 0.87          -40.99 ± 0.63        8.70 ± 0.15      64.21 ± 0.78   14
  7M2KS244G/V1104A/ex31A/A2075V   -5.66 ± 0.99^ccc^     -37.10 ± 0.92^ccc^   7.94 ± 0.31      69.29 ± 0.77   11
  ------------------------------- --------------------- -------------------- ---------------- -------------- ----

Parameters (means ± S.E.) were obtained by fitting data of I-V relationships as described in methods; statistical significances are indicated for comparisons vs. rCa~v~1.3~scg~ (a, aa, aaa), vs. A2075V (b, bb, bbb) and vs. S244G/A2075V (c, mL, ccc) (one-way Anova with Bonferroni post-test)

###### **Table 2.** Inactivation time constants of rCa~v~1.3 α~1~-subunit mutations

  ------------------------------- ------------------ -------------------- ------------------- ----------------- ----
                                  50ms (I~50~/I)     τ~fast~ (ms)         \% τ~fast~          τ~slow~ (ms)      n
  Ca~v~1.3 constructs                                                                                           
  rCa~v~1.3~scg~                  0.36 ± 0.03        13.54 ± 1.05         64.37 ± 2.41        372.7 ± 41.7      12
  rCa~v~1.3~L~                    0.65 ± 0.03^aaa^   92.94 ± 8.67^aaa^    63.98 ± 2.50        405.1 ± 27.0      17
  rCa~v~1.3~scg~ constructs                                                                                     
  7M2K                            0.35 ± 0.02        13.43 ± 2.32         62.84 ± 3.81        313.4 ± 63.7      6
  S244G                           0.24 ± 0.03^a^     9.646 ± 0.90^a^      74.79 ± 2.27^a^     315.9 ± 54.7      6
  V11074A                         0.31 ± 0.02        10.51 ± 0.61         67.09 ± 2.68        388.7 ± 58.8      7
  A2075V                          0.74 ± 0.03^aaa^   110.5 ± 15.08^aaa^   42.37 ± 2.78^aaa^   529.6 ± 53.4^a^   12
  S244G/A2075V                    0.59 ± 0.03^aaa^   77.64 ± 10.23^aaa^   61.36 ± 3.99        346.1 ± 31.6      16
  V1104A/A2075V                   0.70 ± 0.06        120.0 ± 9.49         43.08 ± 4.87        541.2 ± 119.7     6
  7M2K/S244G/A2075V               0.66 ± 0.03        77.84 ± 12.29        55.85 ± 6.34        426.8 ± 38.0      6
  S244G/V1104A/A2075V             0.62 ± 0.03        73.57 ± 9.49         54.94 ± 3.84        390.8 ± 39.2      9
  S244G/V1104A/ex31A/A2075V       0.63 ± 0.06        75.09 ± 27.81        53.63 ± 5.73        413.9 ± 100.6     6
  7M2KS244G/V1104A/ex31A/A2075V   0.64 ± 0.04        84.90 ± 14.75        65.23 ± 7.05        375.3 ± 22.5      3
  ------------------------------- ------------------ -------------------- ------------------- ----------------- ----

Time constants for the fast (τ~fast~) and slow (τ~slow~) component of inactivation during 2.5 sec depolarizations to V~max~ were obtained by nonlinear curve-fitting of the experimental data to a double exponential function; % τ~fast~, contribution of the fast component; a non-inactivating component was \< 10% in all experiments and is therefore not shown.

rCa~v~1.3~scg~ transcripts were not detected in rat scg RNA preparations
------------------------------------------------------------------------

Comparison of the aa sequence of the rCa~v~1.3~scg~ α~1~ construct with the canonical rat Ca~v~1.3~L~ α~1~ sequence revealed only minor structural differences ([Fig. 2A](#F2){ref-type="fig"}). Single aa exchanges were found in positions 244 (S in rCa~v~1.3~scg~, G in rCa~v~1.3~L~), 1104 (V to A) and 2075 (A to V), an alternatively spliced locus (exon 31 in rCa~v~1.3~scg~ vs. exon 31A in rCa~v~1.3~L~) also found in mouse and human,[@R21] and a polymethionine stretch with two additional lysines at the N-terminus (7M2K), which is present in the mRNA of different species but was absent in the rCa~v~1.3~scg~ construct.[@R15] Inspection of the rat genomic cacna1d-sequence (GenBank accession number NW_047469.2) revealed the DNA sequence previously reported for rCa~v~1.3~L~ α~1~-subunits, isolated from pancreas (D38101, D38102), brain (M57682), and kidney (M99221). We found no genomic evidence for any of the single amino acid differences reported for rCa~v~1.3~scg~. The residues concerned are also highly conserved in other species, such as human (EU363339.1), mouse (NP_001077085), cattle (NP_001179954), and rabbit (XP_002713437), with no evidence for variation as found in rCa~v~1.3~scg~. Since the three single aa differences S244G, V1104A, A2075V had been detected in scg preparations[@R15] but not in rat brain,[@R22] we re-evaluated the abundance of these variants in Sprague-Dawley scg preparations, by using a transcript-scanning approach. rCa~v~1.3~L~ and rCa~v~1.3~scg~-specific sequences were determined by restriction enzyme profiling of cloned PCR products. Neither S244 (n = 122) nor V1104 (n = 106) or A2075 (n = 109) could be detected (they would appear as undigested PCR products in lanes b, and digested PCR products in lanes c in [Figure 2B](#F2){ref-type="fig"}) in more than hundred clones analyzed for each position. This suggests minimal or no rCa~v~1.3~scg~ expression in adult rat scg. Direct sequencing of PCR products amplified from two independent reverse transcriptions also revealed no evidence for low abundance DNA sequence variations in the codons concerned ([Fig. 2C](#F2){ref-type="fig"}). Therefore our data do not confirm the expression of rCa~v~1.3~scg~-specific sequences in scg.

![**Figure 2.** Structural differences between rCa~v~1.3~scg~ and rCa~v~1.3~L~ and tissue expression. (A) Scheme of Ca~v~1.3 α1-subunits showing the approximate positions of structural differences (highlighted in gray) between rCa~v~1.3~L~ and Ca~v~1.3~scg~ as described in the text. (B) Restriction enzyme mapping of amino acid positions (pos) 244, 1104 and 2075; representative agarose gel separations of digests are shown. PCR products of regions of interest were amplified from rat scg cDNA, cloned and analyzed by colony PCR. Lanes a, undigested PCR products; lanes b, PCR products treated with enzymes only digesting DNA sequence reporting amino acid residues G244 (Hyp188III, n = 122 clones analyzed), A1104 (Hin6I, n = 106), or V2075 (Alw26I, n = 109); lanes c, control treatment with enzymes specifically digesting PCR products containing sequence for S244 (BtsIMutI, n = 16), V1104 (SduI, n = 13) or A2075 (Bpu10I, n = 14). For the latter enzymes positive control digests of PCR products amplified using rCav1.3~scg~ cDNA plasmids as a template are also shown. Note that differences in fragment size between sample and controls arise from use of different primer positions (see methods). (C) Results of direct sequencing of PCR products containing the reported nucleotide exchange. Nucleotide numbers are given according to the reference sequence (NM_017298.1). The nucleotide and corresponding amino acid sequence of the PCR products amplified from rat superior cervical ganglion cDNA (scg sequence) are shown in comparison with the respective rCa~v~1.3~scg~ sequence below. The critical nucleotide and resulting amino acid differences are highlighted. No additional low abundance nucleotide sequences could be detected, arguing against the presence of detectable amounts of rCav1.3~scg~ transcripts.](chan-6-197-g2){#F2}

As shown above we found profound functional differences between rCa~v~1.3~scg~ and rCa~v~1.3~L~. Therefore the observed aa differences provided us with a unique opportunity to study their role for Ca~v~1.3 channel function.

Impact of single and combined mutations on rCa~v~1.3~scg~ gating
----------------------------------------------------------------

To reveal the contribution of these minor structural differences for channel gating we first converted the single aa exchanges individually (S244G, V1104A, A2075V) and in combination to rCa~v~1.3~L~ residues within the rCa~v~1.3~scg~ backbone and tested to which extent this resulted in restoration of rCa~v~1.3~L~ functional properties. We also analyzed the alternatively spliced locus (exon 31/exon 31A) and the N-terminal polymethionine stretch with two additional lysines (7M2K). S244 in rCa~v~1.3~scg~ is located at the cytoplasmatic end of segment S4, which forms part of the voltage sensing domain in repeat I ([Fig. 2A](#F2){ref-type="fig"}). Conversion of S244 to the corresponding glycine in rCa~v~1.3~L~ (S244G) shifted the activation threshold (by 6.03 ± 1.47 mV, p \< 0.001) and V~0.5~ (3.06 ± 1.59 mV) to more positive voltages ([Fig. 3A](#F3){ref-type="fig"}, [Table 1](#T1){ref-type="table"}). It also induced a significant decrease in k~act~ ([Table 1](#T1){ref-type="table"}). S244G enhanced inactivation of I~Ca~ during depolarizations to test potentials over a broad voltage range ([Fig. 3B](#F3){ref-type="fig"}, [Table 2](#T2){ref-type="table"}). Since no increase in inactivation was observed for I~Ba~ ([Fig. 3B](#F3){ref-type="fig"}) this enhancement reflected accelerated CDI. Faster inactivation resulted from a significant decrease of the time constant of the fast inactivating component (τ~fast~) and a significant increase in its contribution to inactivation ([Fig. 4](#F4){ref-type="fig"}; [Table 2](#T2){ref-type="table"}). As an estimate for changes in channel Po we compared the relative size of ON gating currents (Q~on~) with tail current amplitude (I~tail~). This ratio was similar for rCa~v~1.3~scg~ and S244G suggesting that the mutation did not change Po ([Fig. 5](#F5){ref-type="fig"}). Taken together, mutation S244G in rCa~v~1.3~scg~ partially restores the more positive activation threshold of rCa~v~1.3~L~ but accelerates CDI. Among a large number of point mutations previously studied,[@R23]^,^[@R24] S244G is to our knowledge the first mutation capable of significantly enhancing CDI. This finding was surprising because the mutation was expected to reduce CDI to the more moderate level observed in rCa~v~1.3~L~.

![**Figure 3.** Voltage-dependent activation of rCa~v~1.3~scg~ mutants. (A) Normalized I-V relationships of rCa~v~1.3~scg~ mutations S244G (▼), A2075V (△), double mutation S244G/A2075V (■), and "all" amino acid exchanges (resulting in rCa~v~1.3~L~ sequence in the rCa~v~1.3~scg~ plasmid) (□). Lines represent best fits to the equation described in methods, parameters are given in [Table 1](#T1){ref-type="table"}. I-V curves for rCa~v~1.3~L~ (gray), and rCa~v~1.3~scg~ (broken line) are shown for comparison (taken from [Figure 1A](#F1){ref-type="fig"}). (B) Voltage dependence of CDI for rCa~v~1.3~scg~ (○), rCa~v~1.3~L~ (●), S244G (▼), A2075V (△) and double mutant S244G/A2075V (▼). r~50~, fraction of peak current remaining at the end of 50-ms depolarizations to the indicated test potentials. I~Ba~ measured under the same conditions is indicated for some of the constructs (same symbols, dashed line). Inset: F-values (means ± S.E.) were defined as the maximal difference between r~50~ values of I~Ba~ and I~Ca~ observed within the investigated voltage range (at -19 mV for all constructs). F-values of all constructs were significantly different from rCa~v~1.3~scg~ (one-way ANOVA with Bonferroni post-test) and from rCa~v~1.3~L~, with the exception of S244G/A2075V which was not different from rCa~v~1.3~L~.](chan-6-197-g3){#F3}

![**Figure 4.** I~Ca~ inactivation of rCa~v~1.3~scg~ mutants. I~Ca~ inactivation of rCa~v~1.3~scg~ mutants during the first 500 ms of a 2.5 sec test pulse to V~max~. Mutants S244G, A2075V and S244G/A2075V are illustrated. Data are shown as means (black line) with SE (gray). Inactivation time courses of rCa~v~1.3~L~ and rCa~v~1.3~scg~ (taken from [Figure 1B](#F1){ref-type="fig"}) are shown for comparison (light gray). Inactivation parameters are given in [Table 2](#T2){ref-type="table"}.](chan-6-197-g4){#F4}

![**Figure 5.** Changes in maximal Po of rCa~V~1.3~scg~ mutants. Po of rCa~v~1.3~scg~, rCa~v~1.3~L~ and the indicated mutants was determined from the ratios of maximal tail (ionic) current (I~tail~) to Q~on~ (ON gating current) amplitude. Data shown are means ± S. E.. In comparison to rCa~v~1.3~scg~ Po was significantly changed for all constructs except for mutant S244G (one-way ANOVA with Bonferroni post-test). The insert shows representative current traces for rCa~v~1.3~scg~ (black) and rCa~v~1.3scg mutant A2075V (gray). Currents are normalized to maximal I~tail~ amplitude. The experimental pulse protocol is shown above.](chan-6-197-g5){#F5}

In contrast to S244G, reverting A2075 in rCa~v~1.3~scg~ to the corresponding valine in rCa~v~1.3~L~ (A2075V) inhibited CDI ([Fig. 3B](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). Quantification over a large voltage range revealed that CDI was strongly decreased and even significantly slower than in rCa~v~1.3~L~ (see F-values in [Figure 3B](#F3){ref-type="fig"}). Voltage-dependent inactivation (i.e., inactivation kinetics of I~Ba~, VDI) was not affected ([Fig. 3B](#F3){ref-type="fig"}). Slowing of CDI by the A2075V mutation resulted in a significant about 8-fold increase in τ~fast~ and a 22% decrease of the contribution of the fast component ([Fig. 4](#F4){ref-type="fig"}, [Table 2](#T2){ref-type="table"}). Like S244G, A2075V also caused a partial but significant shift of V~0.5~ to more positive voltages by about 6 mV ([Fig. 3A](#F3){ref-type="fig"}, [Table 1](#T1){ref-type="table"}). These data show that although both single mutations shift the channel\'s activation voltage range to more positive voltages, they exert opposite effects on CDI. Also in contrast to S244G, A2075V increased Q~on~ relative to I~tail~ ([Fig. 5](#F5){ref-type="fig"}) suggesting a decrease in Po. Mutation of V1104 in rCa~v~1.3~scg~ to alanine, or inclusion of the 7M2K sequence at the N-terminus ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}) caused no significant effects on V~0.5~, activation thresholds and on current kinetics. We therefore hypothesized that the combined mutation of S244G and A2075V in rCa~v~1.3~scg~ restores most of the gating properties of rCa~v~1.3~L~. In the double mutant S244G/A2075V CDI parameters were restored to values indistinguishable from those of rCa~v~1.3~L~ (Fig. Three and 4). This was again verified over a broad voltage range showing that F-values of S244G/A2075V and rCa~v~1.3~L~ were not significantly different ([Fig. 3B](#F3){ref-type="fig"}). VDI was also not affected by the double mutation ([Fig. 3B](#F3){ref-type="fig"}). Introduction of V1104A into A2075V (V1104A/A2075V) was without noticeable effect on gating parameters ([Table 1](#T1){ref-type="table"}, [Table 2](#T2){ref-type="table"}).

The double mutation S244G/A2075V robustly shifted V~0.5~ by about 10 mV to more positive voltages, thus representing an additive effect of the two individual mutations ([Table 1](#T1){ref-type="table"}). However, it still activated at about 6 mV more negative voltages than rCa~v~1.3~L~ ([Fig. 3A](#F3){ref-type="fig"}, [Table 1](#T1){ref-type="table"}). To further determine the structural basis of this remaining difference we constructed a variety of combined mutations. Inclusion of V1104 and exon31A in S244G/A2075V neither alone nor in combination restored the V~0.5~ of rCa~v~1.3~L~ ([Table 1](#T1){ref-type="table"}). However, the additional insertion of the rCa~v~1.3~L~ N-terminal peptide 7M2K (that completely restored the sequence of rCa~v~1.3~L~ although in a different expression plasmid;[@R25]), restored the voltage activation range of rCa~v~1.3~L~ as expected. This indicates a complex cooperative interaction between 7M2K, exon31 and A1104 for control of activation gating.

Discussion
==========

The recent discovery of a C-terminal modulatory domain within the long C-terminal tail of LTCCs provided a fresh perspective on how these channels undergo automodulatory fine tuning through C-terminal intramolecular protein-protein interaction. In Ca~v~1.4 α~1~-subunits this interaction can completely suppress CDI. This stabilizes very slow inactivation of Ca^2+^ currents as required for continuous Ca~v~1.4 channel activity in retinal photoreceptor terminals.[@R26]^-^[@R28] In Ca~v~1.2 this modulatory domain serves as the structural framework to enable its regulation by cAMP-dependent protein kinase during the flight-and fight response.[@R29]^,^[@R30] Ca~v~1.3 variants with full-length or truncated C-termini show pronounced differences in gating behavior that affect Ca~v~1.3-mediated Ca^2+^ entry during physiological neuron-like firing patterns.[@R8] Therefore the isolation of rat scg Ca~v~1.3 channel transcripts (rCa~v~1.3~scg,~ GenBank accession numbers: AF370010, AF370009) containing specific single amino acid differences and completely lacking this regulatory capacity[@R11]^,^[@R15] implied a puzzling species difference. As the exchanges are not predicted by the genomic cacna1d sequence (GenBank accession number: NW_047469.2), they could result from nuclear pre-mRNA editing by adenosine deaminases (ADARs). This is the most abundant type of RNA editing found in higher eukaryotes and has been reported for Ca~v~1.3 α~1~-subunits.[@R10]^,^[@R31] It results in a post-transcriptional single nucleotide change from adenosine to inosine, which is interpreted as guanosine by the translation machinery. As evident from [Figure 2C](#F2){ref-type="fig"}, however, this mechanism cannot explain the single amino acid changes in rCa~v~1.3~scg~. Our PCR analysis of reverse transcribed RNA samples from rat scg could not detect the single amino acid differences specifically reported for rCa~v~1.3~scg~ (GenBank accession numbers: AF370010, AF370009). We therefore conclude that, if rCa~v~1.3~scg~ transcripts exist at all, they are of very low abundance. However, we cannot rule out the possibility that rCa~v~1.3~scg~ is the result of molecular processing not yet described for Ca~v~1.3 α~1-~subunits (such as utilization of microexons[@R32]) that occurs conditionally (e.g., in an age or health state-dependent manner) and has thus evaded our analysis.

We show that the long rCa~v~1.3 α~1~-subunit splice variant isolated from rat pancreas exhibits gating properties indistinguishable from those cloned from human and mouse. We found that the mutation of two aa residues in rCa~v~1.3~scg~ to rCa~v~1.3~L~ sequence also restored most of the gating properties of rCa~v~1.3~L~. Both mutations additively contributed in shifting V~0.5~ to more positive voltages. However, their effects on CDI were more complex. Whereas S244G enhanced CDI beyond inactivation of rCa~v~1.3~scg~, A2075V caused a strong reduction of CDI that was even slower than for rCa~v~1.3~L~. These opposite effects eventually led to inactivation of S244G/A2075V very similar to rat and human Ca~v~1.3~L~. These data also suggest that Ca~v~1.3 constructs containing either serine in position 244 or alanine in position 2075, but not both, would display unusual biophysical properties different from all other Ca~v~1.3 splice variants described so far. However, the presence of both induced gating properties very similar to human and mouse short Ca~v~1.3.

The cytoplasmic side of the S4 transmembrane voltage-sensor helices transmits voltage-dependent movements to their S4-S5 linkers which make contacts to the pore-forming S6 helices and thereby participate in channel opening and closing.[@R33] Accordingly, mutations in this region affect channel gating as, for example, seen in mutations associated with human diseases. Mutation S229P in Ca~v~1.4 (causing CSNB2) completely prevents channel opening[@R34] and S218L in Ca~v~2.1 (causing Familial Hemiplegic Migraine Type I) causes a strong negative shift in V~0.5~ and a slowing of VDI.[@R35] It is unknown how S244G could enhance CDI even beyond the fast CDI already seen in rCa~v~1.3~scg~. In addition, how can we explain the observation that mutations S244G and A2075V both cause a similar positive shift of V~0.5~ but show opposite effects on CDI? One possible unifying interpretation is based on a recent model assuming an allosteric CDI mechanism[@R24] in which inactivation represents an allosteric modulation of channel opening. It assumes that channels can adopt either a normal gating mode or an "inactivated" mode in which their opening is allosterically inhibited but not completely prevented by interaction with calmodulin. In this model mutations that promote opening would also enhance opening of the inactivated mode and therefore diminish CDI~max~ (i.e., CDI observed when all channels are in the inactivated mode). Conversely, mutations diminishing opening (i.e., increasing V~0.5~) could enhance CDI~max~. However, with increasing V~0.5~ also the fraction of channels in the inactivated mode at steady-state (F~CDI~)[@R24] would decrease, due to diminished Ca^2+^ entry to drive CDI. This would result in a bell-shaped relationship between relative changes in V~0.5~ and observed CDI.[@R24] However, mutations that strongly suppress maximum Po would also reduce F~CDI~ that resulted in observed CDI values to fall below the predicted bell-shaped curve. Therefore we measured the relationship of Q~on~-gating currents to I~tail~ as an estimate for changes in maximum Po.[@R9]^,^[@R24] We found no changes for S244G but a strong reduction of maximal Po for A2075V. Accordingly, the increase in CDI induced by S244G can be explained by the more positive V~0.5~ in the absence of changes in Po. In contrast, diminished CDI of A2075V must be determined by its lower maximal Po. Moreover, A2075V is known to decrease the affinity of the C-terminal regulatory domain for the apo-calmodulin binding site on the channel[@R11] which must also be regarded as a strong inhibitory factor for CDI.

Our data also revealed a small but significant effect of an N-terminal sequence comprising a poly-methionine stretch followed by two lysine residues, which is not present in the rCa~v~1.3~scg~ construct. The first methionine must comprise the transcriptional start site. It is unlikely that methionine aminopeptidase removes this and subsequent methionines, because methionine residues in the second position do not support efficient cleavage.[@R36] It is therefore likely, that this polymethionine stretch (and the two adjacent lysine residues), which is conserved across species (e.g., mouse, human, cattle, rabbit) is present in Ca~v~1.3 α~1~-subunits and contributes to the more positive activation voltage range of rCa~v~1.3~L~.

We conclude that rCa~v~1.3~scg,~ should not be regarded as contributor to the previously described functional heterogeneity of Ca~v~1.3 channels as long as no unequivocal bioinformatic and biochemical evidence indicates significant expression in scg neurons or other tissues. Note that at present no evidence exists for any species differences with regard to Ca~v~1.3 channel gating. As Ca~v~1.3 channels are currently a promising target for drug discovery to develop neuroprotective agents in Parkinson disease,[@R3]^,^[@R37] the complex stabilization of gating properties by opposite effects of two single amino acid changes should be taken into account when interpreting previous studies employing rCa~v~1.3~scg~ α~1~ constructs on the modulation of channel currents by protein interactions,[@R16]^,^[@R38] enzymes,[@R39] or mutations. [@R24]

Methods
=======

RNA preparation
---------------

Five male Sprague-Dawley rats (10--11 weeks old) were euthanized by carbon dioxide inhalation in a saturated chamber in accordance with established welfare guidelines. The superior cervical ganglia (scg) were excised and stored in liquid nitrogen immediately. Total RNA was purified from pooled tissue using the Qiagen RNeasy Lipid Tissue Kit according to manufacturer\'s protocol. RNA concentration was measured using Nanodrop (NanoDrop 1000 Spectrophotometer, Thermo Scientific), and RNA quality was evaluated via separation of 28S and 18S rRNA bands on a denaturing agarose gel. One µg of total RNA was reverse transcribed at 55°C (RevertAid™ Premium First Strand cDNA Synthesis Kit, Fermentas) using random hexamer primers in a reaction volume of 20 µl. The concentration of the cDNA yielded was referred to in RNA equivalents, i.e., 1 µl of reverse transcription reaction (cDNA) was equivalent to 50 ng of RNA.

Transcript scanning and restriction analysis
--------------------------------------------

PCR reactions were performed with Pfu DNA Polymerase (EP0501, Fermentas) and 50 ng RNA equivalent from independent reverse transcriptions (95°C for 2 min, 30 cycles of 95°C for 30 sec, 58°C for 30 sec, 72°C for 1 min 15 sec, final elongation at 72°C for 5 min; 0.5 µM primer, 2 mM MgSO~4~, 0.2 mM dNTP). Specific primer pairs (position (pos) 244: Fwd, 5′-GGACTGCTGCTGCATCCTAATGCT-3′; Rev, 5′-GGAGCTGGGTCCTCTTCAGCTAC-3′; pos 1104: Fwd 5′-TGCACAGATGAGGCCAAAAGTAACC-3′; Rev 5′- ACGGTGAAGACCCCCGTGAA-3′; pos 2075: Fwd, 5′-GCCGTCGCTACACCGCAGTT-3′; Rev, 5′- CCTCTCGCCCAGGGTCTGGT-3′) amplified fragments of 398 bp (pos 244), 620 bp (pos 1104) and 395 bp (pos 2075), respectively.

PCR products of independent PCR reactions, with independently generated cDNA templates, were purified by electrophoresis in 1.5% agarose gels and extracted using the NucleoSpin Kit (Macherey-Nagel) and ligated with the pJET1.2/blunt vector (Clone JET PCR Cloning Kit, Fermentas) for transformation of DH5α cells. Resulting clones were analyzed by colony PCR (95°C for 3 min, 30 cycles of 95°C for 30 sec, 60°C for 30 sec, 72°C for 45 sec, final elongation at 72°C for 5 min) using PCR Master Mix (K0171, Fermentas) primers flanking the multiple cloning site of the vector (Fwd, 5′- CGACTCACTATAGGGAGAGCGGC-3′, Rev, 5′-AAGAACATCGATTTTCCATGGCAG-3′). One aliquot of the PCR reaction was used as undigested control; other aliquots were used for restriction enzyme analysis. For each amino acid position analyzed two randomly chosen clones were also verified by sequencing (Eurofins MWG Operon, Germany).

For all clones restriction analysis was performed with enzymes specifically digesting rCa~v~1.3~L~ - containing residues: Hpy188III for G244, Hin6I for A1104, Alw26I for V2075. As a control about 10% of clones were additionally analyzed with enzymes specifically digesting rCa~v~1.3~scg~ sequence: BtsIMutI for S244, SduI for V1104, Bpu10I for A2075. Specific primers (see above) were used to generate positive control PCR fragments from cloned rCa~v~1.3~scg~.[@R39] Expected product sizes (bp) for samples were as follows: G244: a, 517; b, 217 + 152 + 63 + 50 + 35; c, 517; A1104: a, 739; b, 529 + 210; c, 739; V2075: a, 514; b, 261 + 253; c, 514. Expected digestion product sizes (bp) for controls: S244: 215 + 183; V1104: 468 + 152; A2075: 199 + 196. ([Fig. 2B](#F2){ref-type="fig"}).

For direct PCR product sequencing gel extracted samples were directly sequenced (Eurofins MWG Operon, Germany) after PCR amplification from two independently generated scg cDNA templates and gel electrophoresis as described above.

Cell culture and transient expression
-------------------------------------

Human embryonic kindney cells (HEK293), stably expressing the SV40 temperature sensitive T antigen (tsA-201), were grown in Dulbecco\`s modified Eagle's medium (DMEM), supplemented with 10% v/v fetal calf serum (10270--106, Gibco), 2 mM L-glutamine (25030--032, Gibco), and 10 units/ml penicillin (P-3032, Sigma) /streptomycin (S-6501, Sigma), maintained at 37°C an 5% CO~2~. Cells were splitted, when reached 80% confluency, using 0.05% Trypsin for cell dissociation. Passage did not exceed 20 numbers. Transient transfection was achieved by standard calcium phosphate precipitation method as described,[@R8] using an equimolar ratio of cDNA encoding rCav1.3~scg~ (generously provided by Diane Lipscombe), rCav1.3~L~ (generously provided by S. Seino) or the respective mutant α~1~-subunits, together with auxiliary β~3~ and α~2~δ. For cell visualization 1 µg of GFP was cotransfected. For whole cell patch clamp measurements cells where then plated on 35 mm polystyrene dishes (Falcon, Heidelberg, Germany), pretreated with poly-[l]{.smallcaps}-lysine.

Cloning of Ca~v~1.3 α~1~-subunit constructs
-------------------------------------------

Mutations 7M2K and A2075V were introduced into rCa~v~1.3~scg~ by PCR using Pfu polymerase (EP0501, Fermentas). Cloning of the rCa~v~1.3~scg~ mutants S244G and V1104A as well as exchange of exon 31a was performed by exchange of regions of interest between rCa~v~1.3~L~ and rCa~v~1.3~scg~ or rCa~v~1.3~scg~ A2075V. After restriction enzyme digestion fragments of rCa~v~1.3~L~ (carrying rCa~v~1.3~L~ specific- sequence) were incorporated into rCa~v~1.3~scg~ or rCa~v~1.3~scg~ A2075V to replace the Ca~v~1.3~scg~ - specific sequence. Enzyme combinations were as follows: S244G: BsiWI, BamHI; V1104A: BamHI, BglII, KpnI; ex 31A: EcoRV, BamHI. rCa~v~1.3~L~, rCa~v~1.3~scg~ and all mutations were verified by sequencing (Eurofins MWG Operon, Germany).

Electrophysiology
-----------------

For whole cell patch clamp recordings borosilicate glass electrodes where pulled (micropipette puller, Sutter Instruments) and fire polished (microforge, Narishinge MF-830), having a final resistance of 2--5 MΩ. Cells were recorded in whole-cell configuration using an Axopatch 200B amplifier (Axon instruments). Data were digitized (Digitizer 1322A, Axon Instruments) and analysis was performed by pClamp 10.2 software (Axon Instruments). The recording solutions contained in mM: pipette solution: 135 CsCl, 10 HEPES, 10 Cs-EGTA, 1 MgCl~2~ adjusted to pH 7.4 with CsOH; bath solution: 15 CaCl~2~ or BaCl~2~, 10 HEPES, 150 choline-Cl, and 1 MgCl~2~, adjusted to pH 7.4 with CsOH. Cells were held at a holding potential of -80 mV, before current-voltage (I-V) relationships were obtained by applying 10 ms square pulse protocol to various test potentials. For leak subtraction a P/4 protocol was used. I-V curves were fitted to the equation I = G~max~ (V-V~rev~) / {1+exp\[(V-V~0.5~)/k~act~\]}, where V~rev~ is the extrapolated reversal potential, V is the test potential, I is the peak current amplitude, G~max~ is the maximum slope conductance, V~0.5~ is the half maximal activation voltage and k~act~ is the slope factor. Inactivation was determined by a 2.5 sec long pulse to V~max~, and fit by standard double exponential decay, via Graph Pad Prism 5 (GraphPad Software Inc.). Voltage dependence of the inactivation time course was determined by a 300 ms long step protocol to various test potentials.

As an estimate for the maximal channel open probability we compared the amplitude of ON-gating currents (Q~on~) with ionic tail currents (I~tail~) during 10 ms test pulses to 61 mV and repolarization to -80 mV.

Statistics
----------

Data analysis was performed by Clampfit 10.2 (Axon Instruments) and Sigma Plot 11 (Systat Software Inc.). All data are represented as mean ± S.E.. For statistical analysis one-way ANOVA with Bonferroni post-test or Student's t-test was performed using Graph Pad Prism 5.1 software (GraphPad Software Inc.). Significance level was set to α error lower than p \< 0.05.
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aa

:   amino acid

CDI

:   Calcium dependent inactivation

CTM

:   C-terminal modulatory domain

LTCC

:   L-type calcium channel

Po

:   open probability

scg

:   superior cervical ganglion

V~0.5~

:   voltage of half maximal activation
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